MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 2 (2005), Issue 8 (August)

1. Methicillin-resistant Staphylococcus aureus (MRSA) isolated from animals and veterinary personnel in Ireland.
   Vet Microbiol, 109(3): 285-96. [Abstract] [Full-text]
2. Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis.
   J Antimicrob Chemother, 56(2): 287-91. [Abstract] [Full-text]
3. Clinical audit of linezolid use in a large teaching hospital.
   J Antimicrob Chemother, 56(2): 423-6. [Abstract] [Full-text]
4. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares.
   J Hosp Infect, 61(1): 62-7. [Abstract] [Full-text]
5. Focus group data as a tool in assessing effectiveness of a hand hygiene campaign.
   Am J Infect Control, 33(6): 368-73. [Abstract] [Full-text]
6. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.
   Clin Infect Dis, 41(5): 583-90. [Abstract] [Full-text]
7. Evaluation of two new chromogenic media, CHROMagar MRSA and S. aureus ID, for identifying Staphylococcus aureus and screening methicillin-resistant S. aureus.
   J Clin Microbiol, 43(8): 4242-4. [Abstract] [Full-text]
8. Mannitol salt agar-cefoxitin combination as a screening medium for methicillin-resistant Staphylococcus aureus.
   J Clin Microbiol, 43(8): 3797-9. [Abstract] [Full-text]
9. Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital.
   J Clin Microbiol, 43(8): 3610-4. [Abstract] [Full-text]
10. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity.
    J Infect Dis, 192(5): 811-8. [Abstract] [Full-text]
11. The predominant variant of the Brazilian epidemic clonal complex of methicillin-resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells.
    J Infect Dis, 192(5): 801-10. [Abstract] [Full-text]
12. Transregional spread of a single clone of methicillin-resistant Staphylococcus aureus between groups of drug users in Switzerland.
    Infection, 33(4): 273-7. [Abstract] [Full-text]
13. Optimisation of intact cell MALDI method for fingerprinting of methicillin-resistant Staphylococcus aureus.
    J Microbiol Methods, 62(3): 273-84. [Abstract] [Full-text]
14. Anti-MRSA agents: under investigation, in the exploratory phase and clinically available.
    Expert Rev Anti Infect Ther, 3(4): 505-53. [Abstract] [Full-text]
15. Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital.
    Age Ageing, 34(5): 456-62. [Abstract] [Full-text]
16. European status of resistance in nosocomial infections.
    Chemotherapy, 51(4): 177-81. [Abstract] [Full-text]
17. Serious consequences to the use of cephalosporins as the first line of antimicrobial therapy administered in hemodialysis units.
    Nephron Clin Pract, 101(2): c58-64. [Abstract] [Full-text]
18. Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 49(9): 3789-93. [Abstract] [Full-text]
19. The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections.
    Scand J Infect Dis, 37(9): 651-6. [Abstract] [Full-text]
20. Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus.
    Phytother Res, 19(6): 538-42. [Abstract] [Full-text]
21. Surveillance and epidemiology of MRSA bacteraemia in the UK.
    J Antimicrob Chemother, 56(3): 455-62. [Abstract] [Full-text]
22. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    J Antimicrob Chemother, 56(3): 519-23. [Abstract] [Full-text]
23. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
    J Antimicrob Chemother, 56(3): 513-8. [Abstract] [Full-text]
24. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
    J Cyst Fibros, 4(3): 205-7. [Abstract] [Full-text]
25. Inhibitory effect of antimicrobial agents and anisodamine on the staphylococcal superantigenic toxin-induced overproduction of proinflammatory cytokines by human peripheral blood mononuclear cells.
    J Infect Chemother, 11(4): 192-5. [Abstract] [Full-text]
26. New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment.
    J Infect Chemother, 11(4): 182-8. [Abstract] [Full-text]
27. Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion.
    J Infect Chemother, 11(4): 177-81. [Abstract] [Full-text]
28. Risk factors for Staphylococcus aureus infection in liver transplant recipients.
    Liver Transpl, 11(9): 1093-9. [Abstract] [Full-text]

© 2004-2008 MRSA Research Today. All Rights Reserved.